Geron reported $25.78M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Amgen AMGN:US $ 4.33B 1.37B
Aurinia Pharmaceuticals Inc AUP:CN 53.75M 2.3M
Bio Techne TECH:US $ 194.5M 4.05M
Cti Biopharma CTIC:US $ 23.38M 3.88M
Cytokinetics CYTK:US $ 74.64M 17M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Exelixis EXEL:US $ 276.8M 14.63M
Genmab GEN:DC 1.42B 235M
Geron GERN:US $ 25.78M 3.21M
Gilead Sciences GILD:US $ 3579M 392M
Macrogenics MGNX:US $ 68.65M 2.39M
Novartis NOVN:VX 10.13B 319M
Novavax NVAX:US $ 485.99M 157.86M
Pain Therapeutics PTIE:US $ 9.75M 4.62M
Seattle Genetics SGEN:US $ 722.02M 243.94M
YTE INCY:US $ 577.58M 12.7M